[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$hrow
Harrow Health ($HROW) enters commercialization agreement for ophthalmic biosimilars, sparking investor interest. Analysts are bullish on $HROW, citing strong growth potential and a favorable market position.
About $hrow
Harrow Health, Inc. (HROW) is a pharmaceutical company focused on the ophthalmic market.
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Month: XXXXXXX +12%
1-Year High: XXXXXX on 2025-05-16
1-Year Low: XXX on 2025-04-27
| Social Network | X |
|---|---|
| Engagements | XXXXXX |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +614%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $hrow in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +1,002%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27
The most influential creators that mention $hrow in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @LogicalThesis | X | XXXXXX | X | XXXXXX |
| @SteveDJacobs | X | XXXXX | X | XXXXX |
| @Biomaven | X | XXXXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-04-28
1-Year Low: XX% on 2025-07-02
Most Supportive Themes
- Commercialization and Growth: (60%) Positive sentiment around Harrow Health ($HROW) due to commercialization agreements, distribution capabilities, and potential revenue from Vevye.
- Investment Interest: (30%) Positive mentions of $HROW in various portfolios and watchlists, indicating potential investment interest.
Most Critical Themes
- Biosimilar Market Dynamics: (10%) Concerns about the Eylea biosimilar space and potential payer dynamics impacting Harrow Health ($HROW).
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
| Total | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
Top assets mentioned In the posts about $hrow in the last XX hours
NVIDIA Corp. (NVDA) SPX6900 (SPX) SPDR S&P XXX ETF Trust (SPY) Amicus Therapeutics, Inc (FOLD) Palantir (PLTR) Alphabet Inc Class A (GOOGL) Amazon.com, Inc. (AMZN) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Regeneron Pharmaceuticals Inc (REGN) Regeneron Pharmaceuticals Inc (REGN)
Top topics mentioned In the posts about $hrow in the last XX hours
stocks, stocks technology, coins defi, stocks consumer cyclical, stocks bitcoin treasuries, stocks financial services, coins bsc, stocks communication services, coins base ecosystem, coins solana ecosystem, stocks industrials, stocks healthcare, coins dao, stocks crypto treasuries, coins nft, coins meme, coins arbitrum, coins gaming, qqq, $qqq, coins layer 1, coins made in usa, stocks consumer defensive, coins lending borrowing, coins exchange tokens, coins gambling, $nvda, spx, $spx, spy, $spy, $fold, coins bitcoin ecosystem, pltr, $pltr, coins layer 2, $googl, amzn, nvda, $amzn, $tgen, $gsrt, portfolio update, coins ai agents, $aaoi, $mdgl, $regn, regeneron pharmaceuticals inc, evo, oscr, $evo, $cphto, $oscr, coins dot, $meli, $tgtx, stocks basic materials, investment, $aapl, stocks energy, stocks real estate, $nktr, $rpid, $arqt, $sndx, $psnl, $cifr, $glxy, $ftek, $invz, $evlv, $aip, $pubm, $mgni, $ampl, galaxy digital, cipher mining, $crnc, $geni, coins ai, $elvn, $wulf, $spry, $amtm, terawulf, $atro, $srrk, $clpt, $intr, $icu, $cpng, $ghrs, stocks defense, $tvrd, $omse, $kala, $inva, $leu, $janx, googl
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@aahmad1581 current portfolio and ytd performance: Cash (24%) $CPH.TO (14%) $CPNG (11%) $NTDOY (8.5%) $GOOG (7%) undisclosed (6.5%) $DMGI.V (6%) $TGTX (4.5%) $NNI (4%) $HROW (3%) $ACFN (2%) $AMTM (2%) $REGN (2%) $COVCF (1%) $ARBKL (1%) all others (3.5%)"
@astridwilde1 on X 2025-07-19 01:49:31 UTC 11.2K followers, XXX engagements
"Loaded $HROW $Pags and $Stne sold $Tgen on the overnight XX% pop thanks @SixSigmaCapital for all the guidance"
@RoySourav1787 on X 2025-07-19 00:48:34 UTC XXX followers, XXX engagements
"$HROW Attached is a B. Riley analyst note regarding HROW issued yesterday entitled: "Breaking News" B. Riley has a 'Buy' rating on HROW with a $XX price target. cc: @MaxTheComrade"
@CorleoneDon77 on X 2025-07-18 16:50:37 UTC 5263 followers, XXX engagements
"The Eylea biosimilar space is a bit of a mess right now. $REGN formulation patent seems to expire in 2027 but they have a deal for another competitor to enter in 2026 and $AMGN is already on the market at-risk (they don't use a buffer). So likely for $HROW this will be a 2027 story but same dynamics apply as for Lucentis. So then I would see tremendous financial incentives for payers to require Eylea biosimilar step-therapy before paying for Eylea HD or Vabysmo"
@Biomaven on X 2025-07-18 14:59:44 UTC 8503 followers, XXX engagements